Literature DB >> 7229627

Antibody reactive in antibody-dependent cell-mediated cytotoxicity following influenza virus vaccination.

S Vella, G Rocchi, S Resta, M Marcelli, A De Felici.   

Abstract

The antibody reactive in antibody-dependent, cell-mediated cytotoxicity (ADCC) to influenza virus-infected cells was measured in two groups of seven volunteers each, before and after immunization with inactivated or live attenuated A/Victoria/3/75 influenza virus vaccines. Age-matched controls were seven adult individuals who experienced natural influenza infection due to A/Victoria/3/75-like virus strain. After inactivated whole influenza virus immunization all the subjects showed a significant rise of the antibody reactive in ADCC (from a mean value of 4.7% to 17.1% cytotoxicity, before and 5 weeks after immunization, respectively) as well as of hemagglutination inhibition (HI) antibody (fourfold or greater increase). These immune responses were similar to those observed among naturally infected controls. After live attenuated virus vaccination, no significant increase in titer of antibody reactive in ADCC was detected, even though the vaccine induced significant increase of HI antibody titer. Little correlation was found between ADCC and HI antibody rises in sera of recipients of inactivated virus vaccine and of naturally infected individuals while, in live attenuated influenza virus vaccines, the rise of HI antibody titer did not correspond to a significant increase of ADCC antibody titer did not show subjects who developed a significant rise in ADCC antibody titer did not show significant variation in antibody to neuraminidase and/or to complement fixation influenza virus antigens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7229627     DOI: 10.1002/jmv.1890060303

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children.

Authors:  Mary Dawn T Co; Masanori Terajima; Stephen J Thomas; Richard G Jarman; Kamonthip Rungrojcharoenkit; Stefan Fernandez; In-Kyu Yoon; Darunee Buddhari; John Cruz; Francis A Ennis
Journal:  Viral Immunol       Date:  2014-08-20       Impact factor: 2.257

2.  Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.

Authors:  Chen S Tan; Joshua Ghofrani; Emma Geiger; Igor J Koralnik; Stephanie Jost
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.731

3.  High Antibody-Dependent Cellular Cytotoxicity Antibody Titers to H5N1 and H7N9 Avian Influenza A Viruses in Healthy US Adults and Older Children.

Authors:  Masanori Terajima; Mary Dawn T Co; John Cruz; Francis A Ennis
Journal:  J Infect Dis       Date:  2015-03-20       Impact factor: 5.226

4.  Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus.

Authors:  Vikram Srivastava; Zheng Yang; Ivan Fan Ngai Hung; Jianqing Xu; Bojian Zheng; Mei-Yun Zhang
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

5.  Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.

Authors:  Sinthujan Jegaskanda; Thakshila H Amarasena; Karen L Laurie; Hyon-Xhi Tan; Jeff Butler; Matthew S Parsons; Sheilajen Alcantara; Janka Petravic; Miles P Davenport; Aeron C Hurt; Patrick C Reading; Stephen J Kent
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

6.  Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.

Authors:  Carine K Souza; Daniela S Rajão; Crystal L Loving; Phillip C Gauger; Daniel R Pérez; Amy L Vincent
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

7.  Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Authors:  Hillary A Vanderven; Lu Liu; Fernanda Ana-Sosa-Batiz; Thi Ho Nguyen; Yanmin Wan; Bruce Wines; P Mark Hogarth; Danielle Tilmanis; Arnold Reynaldi; Matthew S Parsons; Aeron C Hurt; Miles P Davenport; Tom Kotsimbos; Allen C Cheng; Katherine Kedzierska; Xiaoyan Zhang; Jianqing Xu; Stephen J Kent
Journal:  JCI Insight       Date:  2017-07-06

8.  Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.

Authors:  Hillary A Vanderven; Kathleen Wragg; Fernanda Ana-Sosa-Batiz; Anne B Kristensen; Sinthujan Jegaskanda; Adam K Wheatley; Deborah Wentworth; Bruce D Wines; P Mark Hogarth; Steve Rockman; Stephen J Kent
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

9.  Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.

Authors:  Maurice H J Selman; Sanne E de Jong; Darius Soonawala; Frank P Kroon; Ayola Akim Adegnika; André M Deelder; Cornelis H Hokke; Maria Yazdanbakhsh; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2011-12-19       Impact factor: 5.911

10.  What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.

Authors:  Hillary A Vanderven; Fernanda Ana-Sosa-Batiz; Sinthujan Jegaskanda; Steven Rockman; Karen Laurie; Ian Barr; Weisan Chen; Bruce Wines; P Mark Hogarth; Teresa Lambe; Sarah C Gilbert; Matthew S Parsons; Stephen J Kent
Journal:  EBioMedicine       Date:  2016-04-28       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.